Shares of DuPont de Nemours, Inc. (NYSE:DD - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and twelve have issued a buy recommendation on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $166.60.
A number of brokerages recently issued reports on DD. Zacks Research lowered shares of DuPont de Nemours from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 17th. Citigroup upped their price target on shares of DuPont de Nemours from $168.00 to $170.00 and gave the stock a "buy" rating in a research note on Thursday, July 2nd. Deutsche Bank Aktiengesellschaft raised their price objective on shares of DuPont de Nemours from $174.00 to $180.00 and gave the company a "buy" rating in a research note on Thursday, May 7th. Weiss Ratings restated a "sell (d+)" rating on shares of DuPont de Nemours in a research report on Monday, August 3rd. Finally, JPMorgan Chase & Co. increased their price target on DuPont de Nemours from $171.00 to $172.00 and gave the company an "overweight" rating in a research note on Monday, August 10th.
Read Our Latest Research Report on DD
DuPont de Nemours Stock Performance
Shares of NYSE DD opened at $134.78 on Tuesday. DuPont de Nemours has a 12-month low of $92.49 and a 12-month high of $157.98. The company has a market cap of $18.20 billion, a PE ratio of 299.57, a P/E/G ratio of 1.25 and a beta of 1.06. The stock has a 50 day simple moving average of $138.87 and a 200-day simple moving average of $141.17. The company has a current ratio of 2.43, a quick ratio of 1.82 and a debt-to-equity ratio of 0.23.
DuPont de Nemours (NYSE:DD - Get Free Report) last announced its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.76 by $0.12. The firm had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.81 billion. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%.The firm's revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.12 EPS. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. On average, equities research analysts forecast that DuPont de Nemours will post 7.27 EPS for the current year.
DuPont de Nemours Cuts Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Monday, August 31st will be paid a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $2.40 annualized dividend and a yield of 1.8%. DuPont de Nemours's dividend payout ratio (DPR) is currently 533.33%.
Institutional Investors Weigh In On DuPont de Nemours
Several hedge funds and other institutional investors have recently bought and sold shares of DD. Palisade Asset Management LLC bought a new position in shares of DuPont de Nemours during the 3rd quarter valued at about $26,000. Imprint Wealth LLC bought a new stake in shares of DuPont de Nemours in the 3rd quarter worth approximately $27,000. Basepoint Wealth LLC bought a new stake in shares of DuPont de Nemours in the 4th quarter worth approximately $28,000. Nalls Sherbakoff Group LLC acquired a new stake in DuPont de Nemours during the fourth quarter valued at approximately $29,000. Finally, Measured Wealth Private Client Group LLC acquired a new stake in DuPont de Nemours during the third quarter valued at approximately $30,000. 73.96% of the stock is currently owned by institutional investors.
DuPont de Nemours Company Profile
(
Get Free Report)
DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
